A M Collections Limited

North Star Property Co is a multifaceted firm that specializes in developing and managing retail and residential properties in the Northeast. With a diverse portfolio that includes supermarket and national discounter-anchored open-air community centers, as well as urban mixed-use properties, North Star is committed to enhancing the overall customer experience through superior design and construction standards. For those seeking a place to call home, North Star offers residential properties in New York City that are designed to provide a truly enjoyable living experience. From clean and uplifting common areas to high-end appliances and customizable color schemes, each apartment is crafted with an emphasis on beauty and comfort. The company goes the extra mile by incorporating street art murals by a renowned artist, setting the stage for a vibrant and welcoming atmosphere. Retailers looking to establish themselves in a North Star property can expect more than just a space - they can look forward to being part of a well-presented and attractive environment that is designed to draw in customers and desirable co-tenants. By focusing on architectural and landscape design, merchandising mix, and meticulous property maintenance, North Star creates properties that not only perform well but also offer long-term value and security for tenants and investors alike. Generated from the website content

Access Oncology is a fully integrated biopharmaceutical company based in New York, NY, dedicated to advancing new hope for people with kidney disease. Their team works tirelessly to address complications associated with kidney disease and has developed a commercially available medicine, as well as a late-stage oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) called vadadustat, based on Nobel Prize-winning science. With a mission to protect the kidneys and innovate for better lives, Access Oncology is a trusted leader in the renal community, delivering unique products to patients with kidney disease. Although vadadustat is approved for use in 34 countries, it has not yet received approval from the U.S. Food and Drug Administration.Generated from the website

Opiant Pharmaceuticals, based in New York, NY, focuses on improving the visitor experience on their websites through the use of cookies, including those necessary for site operation and analytics purposes. They prioritize understanding website usage to enhance and evolve their online platforms over time. With a commitment to addressing addiction and behavioral health issues, Opiant Pharmaceuticals engages in research and development activities to drive advancements in therapeutic areas. Their dedication to patient safety, product quality, and corporate integrity underscores their mission to make a positive impact on individuals affected by opioid use disorder.Generated from the website